Eosinophilic Granulomatosis With Polyangiitis Home Care in Mohali
Eosinophilic Granulomatosis With Polyangiitis Recovery and Functional Reconditioning in Mohali
A detailed clinical documentation of how structured home healthcare supported respiratory stabilization, neurological monitoring, fatigue management, and functional recovery in a 49-year-old patient with EGPA following hospital discharge.
Patient Background
Mrs. Simran Gill was a 49-year-old boutique owner living in Mohali, Punjab. She was married and shared her home with her husband, Mr. Manpreet Gill, who served as her primary caregiver, and her daughter, Ms. Harleen Gill, who provided additional support.
Simran had a well-documented history of adult-onset asthma and recurrent sinus problems. These respiratory issues had been part of her medical profile for several years and were managed with routine controller medications and periodic specialist reviews. Her daily life involved running her boutique, which required prolonged standing, physical movement around the store, handling of fabrics and stock, and interacting with customers.
Over the months leading up to her hospitalization, Simran noticed a gradual and concerning change in her health. She began experiencing worsening fatigue that went beyond her usual tiredness after a busy day at the shop. Her muscles felt weaker, particularly in her legs. She developed joint discomfort that made it harder to move around the boutique. Most alarmingly, she noticed a persistent tingling and numbness in both feet. Her breathing, which had been reasonably controlled with her existing asthma medications, became noticeably more difficult during even routine activities.
These symptoms progressively interfered with her ability to manage her boutique independently. Tasks she previously completed without difficulty, such as organizing stock, standing at the counter, or walking through the market for supplies, became increasingly challenging.
EGPA often develops in patients who have a pre-existing history of asthma and sinus disease. The progression from isolated respiratory symptoms to systemic features such as fatigue, muscle weakness, joint pain, and peripheral neuropathy is a recognized clinical pattern in this condition. The overlap of respiratory, neurological, and musculoskeletal symptoms in a patient with known asthma and eosinophilia should prompt evaluation for a systemic vasculitic process.
As her symptoms worsened, Simran was evaluated by a team of specialists including rheumatology, pulmonology, and neurology. Blood investigations revealed marked eosinophilia, a hallmark laboratory finding in EGPA. Evidence of systemic inflammation was also present. The combined clinical picture, including her respiratory history, eosinophil levels, neurological symptoms, and inflammatory markers, was consistent with a diagnosis of Eosinophilic Granulomatosis With Polyangiitis.
EGPA is a rare form of systemic vasculitis, meaning it involves inflammation of blood vessels that can affect multiple organ systems. In Simran’s case, the disease appeared to involve her respiratory tract (asthma and sinus symptoms), peripheral nerves (causing the numbness and tingling in her feet), musculoskeletal system (joint discomfort and muscle weakness), and her overall energy levels.
Clinical Diagnosis
Primary Diagnosis: Eosinophilic Granulomatosis With Polyangiitis (EGPA)
EGPA, previously known as Churg-Strauss Syndrome, is classified as a rare antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. It is characterized by inflammation of small to medium-sized blood vessels and is strongly associated with three clinical features: late-onset asthma, sinus disease, and peripheral blood eosinophilia.
The disease can progress through phases. Many patients initially present with allergic features such as asthma and rhinosinusitis. This may be followed by a phase marked by significant peripheral blood eosinophilia and organ involvement. The vasculitic phase involves inflammation of blood vessels that can damage multiple organs including the peripheral nerves, skin, heart, gastrointestinal tract, and kidneys.
Simran’s Major Clinical Features
- Adult-onset asthma requiring regular controller therapy
- Exertional breathlessness progressively worsening over months
- Chronic rhinosinusitis with recurrent nasal congestion
- Severe fatigue limiting daily activities
- Muscle weakness, particularly in the lower limbs
- Joint discomfort affecting mobility
- Tingling and numbness in both feet (peripheral neuropathic symptoms)
- Reduced walking endurance and difficulty completing household and work activities
Associated Medical Conditions
Moderate Persistent Asthma
Her asthma required regular controller medication and ongoing monitoring. Asthma control had deteriorated in the months before her EGPA diagnosis.
Chronic Rhinosinusitis
Recurrent nasal congestion and sinus symptoms were a persistent feature of her medical history, consistent with the upper airway involvement seen in EGPA.
Peripheral Neuropathic Symptoms
Numbness and tingling in both feet indicated peripheral nerve involvement, a known complication of EGPA that required careful neurological monitoring.
Steroid-Related Weight Gain
Prolonged corticosteroid treatment as part of her EGPA management had contributed to gradual weight gain, which also affected her physical function.
She had no documented chronic kidney disease, which was an important negative finding since EGPA can sometimes affect renal function.
Hospital Treatment
Simran was hospitalized for 9 days after developing worsening breathlessness, generalized weakness, painful sensations in her lower limbs, and increasing difficulty walking. The decision to admit her was driven by the combination of respiratory deterioration, progressive neurological symptoms, and the need for multidisciplinary specialist assessment in a controlled setting.
During her hospitalization, the clinical team conducted a thorough evaluation across multiple domains.
- Respiratory function evaluation including spirometry and clinical assessment of breathlessness severity
- Blood eosinophil levels to quantify the degree of eosinophilia and track treatment response
- Inflammatory markers to assess systemic inflammation burden
- Kidney function tests to screen for renal involvement
- Liver function tests as a baseline for immunomodulatory treatment
- Detailed neurological examination to characterize the peripheral neuropathy
- Blood pressure monitoring, as vasculitis can affect vascular health
- Assessment of medication response during the admission period
Her condition stabilized with appropriate specialist-directed treatment. This included adjustment of her immunomodulatory therapy, optimization of her respiratory medications, and a coordinated plan involving rheumatology, pulmonology, and neurology teams.
Upon stabilization, the hospital team prepared a comprehensive discharge plan that included prescribed immunomodulatory treatment, respiratory medications, asthma management guidelines, infection-prevention measures, a physiotherapy prescription, and scheduled follow-up with rheumatology, pulmonology, and neurology. All medication changes during the admission were made only by her treating specialists.
Why Home Healthcare Was Needed
Despite medical stabilization in the hospital, Simran was far from fully recovered at the time of discharge. The decision to arrange professional home healthcare was driven by several specific clinical needs that could not be safely managed by family support alone.
Respiratory monitoring requirement: EGPA with underlying moderate persistent asthma means that respiratory status can change. A patient who is stable at rest may develop increasing breathlessness during activity. Regular monitoring of oxygen saturation, respiratory rate, and asthma symptoms at home provides early warning of deterioration that family members without clinical training might not recognize until it becomes severe.
Neurological surveillance: Peripheral neuropathy in EGPA can progress. New weakness, worsening numbness, or difficulty lifting the foot (foot drop) can develop. These changes require prompt recognition and reporting to the treating specialists. A trained home nurse understands what to look for during routine assessments.
Functional deconditioning risk: After 9 days of hospitalization with limited physical activity, combined with weeks of progressive weakness before admission, Simran was at significant risk for further physical deconditioning. Without structured rehabilitation at home, her muscle strength, walking tolerance, and balance would likely continue to decline.
Medication safety: EGPA treatment often involves immunomodulatory medications, corticosteroids, respiratory controllers, and possibly other agents. Ensuring correct timing, dosage, and adherence while monitoring for side effects requires clinical oversight that goes beyond what a family member can reliably provide.
Fatigue management: The profound fatigue associated with systemic vasculitis, compounded by steroid therapy and deconditioning, requires a structured approach to activity pacing. Without guidance, patients often push too hard on good days and crash, creating a cycle of overexertion and recovery that delays functional improvement.
Infection prevention: Immunomodulatory treatment for EGPA suppresses the immune system to control inflammation. This increases susceptibility to infections. Home healthcare ensures that infection-prevention practices are followed and that early signs of infection are identified quickly.
At the time of discharge, Simran continued to experience reduced exercise tolerance, significant fatigue, mild lower-limb weakness, numbness in her feet, difficulty walking longer distances, and reduced ability to manage her boutique independently. Home healthcare was positioned to address each of these issues within the familiar environment of her own home.
OPD follow-up visits, while essential for specialist review, provide only periodic snapshots of a patient’s status. EGPA requires continuous observation of respiratory function, neurological status, fatigue patterns, and medication response. The gaps between OPD visits can be where early signs of deterioration are missed. Post-hospital discharge care fills these gaps with structured daily monitoring. This is particularly important for a condition like EGPA where multiple organ systems are involved and where early intervention for flare or complication can significantly affect outcomes.
Home Care Plan by AtHomeCare
The home healthcare plan for Simran was designed around six core objectives: respiratory monitoring, neurological surveillance, functional reconditioning, fatigue management, medication adherence support, and infection prevention. Each component was delivered by the appropriate member of the home healthcare team working in coordination.
Home Nursing
The home nursing component formed the clinical backbone of Simran’s home care. The assigned nurse was responsible for a range of monitoring and support functions that required professional training.
- Monitoring vital signs including blood pressure, heart rate, respiratory rate, and temperature at prescribed intervals
- Checking oxygen saturation using a pulse oximeter when clinically indicated, particularly during or after activity
- Monitoring respiratory symptoms including breathlessness severity, cough, wheezing, and chest tightness
- Recording fatigue levels using structured assessment to track patterns over time
- Monitoring neurological complaints including foot sensation, tingling, numbness, and any new weakness
- Reviewing medication adherence at each visit, confirming that prescribed medications were being taken correctly
- Monitoring weight to track changes related to steroid therapy or disease activity
- Reinforcing infection prevention practices including hand hygiene and avoiding exposure to ill individuals
- Educating the family about warning signs that required urgent medical attention
- Monitoring appetite and nutritional intake as part of overall recovery assessment
Patient Attendant
While the nurse handled clinical monitoring, the patient attendant provided the daily practical support that Simran needed to conserve energy for recovery rather than spending it on physically demanding household tasks.
- Assistance with household activities that Simran could not yet manage independently
- Grocery shopping and errands to reduce Simran’s need for physical excursions
- Light boutique-related tasks to help maintain some continuity in her business
- Transportation support for medical appointments
- Carrying supplies and heavy items that would be unsafe for Simran to handle
Physiotherapy
The physiotherapy at home component was critical for addressing the functional decline that had occurred before and during hospitalization. The treating team recognized that without structured physical rehabilitation, Simran’s deconditioning would worsen and her return to independent activity would be delayed or compromised.
- Restore functional endurance for daily activities
- Improve lower-limb strength affected by deconditioning and neuropathy
- Improve balance and reduce fall risk
- Reduce physical deconditioning through progressive loading
- Increase walking tolerance from baseline
- Improve confidence with activities of daily living
- Gentle range-of-motion exercises to maintain joint flexibility
- Lower-limb strengthening exercises, progressively increased as tolerated
- Sit-to-stand training to improve functional transfer ability
- Balance exercises to address stability concerns related to foot numbness
- Short-distance walking practice with gradual distance increase
- Gradual endurance training paced to respiratory and fatigue status
- Stair practice to improve confidence with vertical mobility
- Functional task training simulating real-world activities
A critical principle of the physiotherapy plan was that exercise intensity was always adjusted according to three factors: fatigue level on that particular day, respiratory symptom status, and neurological findings. If Simran reported increased breathlessness or worsening foot numbness on a given day, the physiotherapist modified the session accordingly rather than pushing through. This approach respected the fluctuating nature of systemic vasculitis recovery.
Nine days of hospitalization with limited mobility, preceded by months of progressive weakness, creates a significant deconditioning effect. Muscle strength declines rapidly with bed rest, and the peripheral neuropathy further compromises the motor units in the lower limbs. Without structured rehabilitation, the body does not automatically regain what was lost. The physiotherapy was not optional comfort care. It was a necessary medical intervention to reverse the functional decline and prevent it from becoming permanent. The connection between physical deconditioning and falls in patients with neuropathy is well established, making fall prevention an integral part of the rehabilitation approach.
Doctor Home Visit
A doctor home visit was arranged as a safety net for situations that required clinical evaluation beyond what the nurse could manage independently.
- Increasing breathlessness not explained by activity level
- Appearance of new wheezing or chest symptoms
- Fever, which in an immunosuppressed patient requires prompt evaluation
- New neurological weakness or significant change in sensation
- Worsening numbness or new difficulty with foot lifting
- Severe or rapidly worsening fatigue
- New swelling, which could indicate disease flare or other complications
- Medication-related concerns or possible side effects
Disease-Specific Monitoring Protocols
Beyond the routine nursing functions, the home team implemented three targeted monitoring protocols specific to Simran’s diagnosis.
The nurse monitored breathlessness using a standardized approach, tracking whether symptoms occurred at rest, during light activity, or during moderate activity. Cough, wheezing, and chest tightness were recorded at each visit. Oxygen saturation was checked during rest and after walking to assess exercise-related desaturation. Exercise tolerance was tracked by comparing walking distance and recovery time over successive sessions.
Simran’s breathlessness increased during faster walking but consistently settled with rest. This pattern was important because it indicated that her respiratory limitation was exertional rather than suggesting ongoing acute inflammation. The nurse documented this pattern and reported it during specialist follow-up visits.
Given her underlying asthma, the home team also reinforced her prescribed asthma management plan, ensuring that reliever and controller medications were being used correctly. Nebulizer therapy was available if prescribed for acute symptom relief.
Because EGPA can involve peripheral nerves and because this involvement can progress, the home team conducted structured neurological assessments. These included checking foot sensation (light touch and whether numbness was present), assessing for tingling or new sensory changes, evaluating muscle strength in the lower limbs, testing foot-lifting ability (dorsiflexion), observing walking stability, and asking about any new weakness.
The critical instruction to the home team was that any sudden or progressive neurological deterioration, such as new weakness, spreading numbness, or developing foot drop, required immediate reporting to the treating team. Peripheral neuropathy in vasculitis can progress rapidly if the underlying inflammation is not adequately controlled, and early recognition of progression allows for timely specialist intervention.
The family maintained a symptom record that covered several markers of potential disease flare or new inflammation. These included fever, new or worsening joint pain, muscle pain, any skin changes (such as rashes or nodules, which can occur in EGPA), increasing fatigue beyond the expected pattern, and any change in respiratory symptoms.
This record served as a communication tool during specialist follow-up visits, providing the treating doctors with a structured account of what had happened between appointments rather than relying on memory alone.
Equipment Used at Home
The home setup included specific equipment to support safe and effective monitoring and rehabilitation. Some of this equipment was already available in the home, while additional items were arranged through medical equipment rental to ensure clinical-grade accuracy.
Daily Care Plan
The daily routine was structured to balance activity with rest, distribute physical demands across the day, and ensure that monitoring occurred at consistent times.
- Symptom review with the home nurse or family
- Prescribed morning medications administered
- Breakfast
- Gentle stretching exercises
- Breathing exercises as prescribed
- Short walk within the home or immediate vicinity
- Lunch
- Planned rest period
- Physiotherapy session (timing adjusted based on morning energy levels)
- Hydration monitoring
- Light household or boutique-related activity (as tolerated)
- Fatigue level assessed and documented
- Gentle walking or continued light activity
- Lower-limb exercises as prescribed by physiotherapist
- Dinner
- Evening medications administered
- Review of respiratory and neurological symptoms for the day
- Medication schedule reviewed for completeness
- Temperature check when clinically indicated
- Fatigue level for the day recorded
- Adequate rest encouraged
- Next day’s activities planned based on current status
Presenting Condition at First Home Assessment
At the first home assessment, Simran was alert and comfortable at rest. She did not require continuous oxygen supplementation at room air. Her vital signs were within acceptable ranges for her condition.
| Clinical Parameter | Finding |
|---|---|
| Blood Pressure | 126/78 mmHg |
| Heart Rate | 84 beats per minute |
| Respiratory Rate | 18 breaths per minute |
| Temperature | 98.2 degrees Fahrenheit |
| Oxygen Saturation | 97% on room air |
| General Condition | Stable |
Despite stable vital signs, Simran reported several active symptoms that defined her functional baseline at the start of home care.
- Mild exertional breathlessness (breathing difficulty during activity that settled with rest)
- Significant fatigue that limited her daily activity duration
- Lower-limb weakness affecting walking endurance and standing tolerance
- Tingling in both feet, present consistently
- Mild joint stiffness, particularly after periods of inactivity
- Reduced walking tolerance compared to her pre-illness baseline
- Difficulty standing for prolonged periods
- Reduced confidence about returning to work at her boutique
Functional Assessment at Baseline
Mobility
At the beginning of home care, Simran’s mobility was limited but she retained the ability to walk independently indoors. She required supervision for longer outdoor walks due to the combination of fatigue, lower-limb weakness, and foot numbness that affected her balance confidence.
| Mobility Parameter | Baseline Status |
|---|---|
| Indoor Walking | Independent |
| Outdoor Walking (Long Distance) | Required Supervision |
| Walking Distance (Approximate) | 160 metres |
| Fatigue After Prolonged Activity | Present |
| Stair Use | Slow but Independent |
| Foot Numbness During Walking | Occasional |
Transfers
Simran was independent with all basic transfers including moving from bed to standing, chair to standing, and on and off the toilet. This was a positive finding because it meant she did not require physical lifting or two-person assistance, which would have significantly increased the complexity of home care.
Activities of Daily Living
Required Assistance With
- Heavy household work
- Prolonged standing
- Carrying materials at her boutique
- Long-distance outdoor walking
- Stock handling and organization
Independent In
- Feeding
- Dressing
- Bathing
- Grooming
- Toileting
- Communication
This functional profile was important for planning the rehabilitation. Simran’s independence in basic self-care meant the physiotherapy could focus on higher-level functional tasks rather than spending time on basic activities. The areas requiring assistance, particularly prolonged standing and heavy lifting, were directly relevant to her work as a boutique owner and became specific targets for functional reconditioning.
Risks Being Monitored
The home healthcare team maintained active surveillance for a range of clinical risks. Each risk was categorized by severity, and the team understood the specific indicators that would signal a change from monitored risk to active problem.
Family Education
A structured family education program was implemented as part of the home care plan. Mr. Manpreet Gill and Ms. Harleen Gill were taught to recognize specific warning signs and to understand the reasoning behind each component of the care plan.
Respiratory Monitoring Education
The family was taught to observe and report specific respiratory changes. These included increasing breathlessness that seemed out of proportion to the activity level, new or worsening wheezing, a persistent cough that was different from Simran’s usual pattern, chest tightness, fever, and a noticeable reduction in her activity tolerance. Simran was advised to follow her prescribed asthma action plan and to use her reliever medication as directed by her pulmonologist.
Infection Prevention Education
Because Simran’s treatment included immunosuppressive medication, infection prevention was emphasized as a daily priority. The family was instructed on proper hand hygiene practices, the importance of avoiding close contact with people who had active respiratory or other infections, the need to discuss appropriate vaccinations with her medical team, and the importance of early reporting of any fever or symptoms suggesting infection. The connection between immunosuppression and infection risk was explained so the family understood this was not an optional precaution but a necessary safety measure.
Neurological Monitoring Education
The family was trained to observe for specific neurological changes. These included any new weakness in the limbs, increasing numbness beyond what Simran already experienced, difficulty lifting the foot while walking (which could indicate developing foot drop), new walking instability or imbalance, and any new falls. The family understood that these findings required same-day communication with the treating team rather than waiting for the next scheduled nurse visit.
Energy Conservation Education
One of the most practical components of family education was energy conservation. Simran was encouraged to divide her tasks into smaller segments rather than attempting to complete everything at once. She was taught to take planned rest breaks between activities, to avoid prolonged standing, to schedule her most demanding tasks during the time of day when her energy was typically highest, and to gradually increase her activity level rather than attempting sudden jumps in physical demand.
Patients with systemic vasculitis often experience profound fatigue that does not improve simply with rest. Without structured pacing, they tend to overexert on days when they feel relatively better, which then triggers a crash that can set recovery back. This boom-and-bust cycle is one of the most common reasons patients with EGPA and similar conditions fail to make functional progress despite being medically stable. Teaching the family to recognize and interrupt this pattern is a meaningful clinical intervention, not just lifestyle advice. Chronic fatigue management requires this kind of structured approach.
Recovery Timeline
The home nursing team conducted the first comprehensive assessment. Vital signs were recorded and found to be stable. Simran’s respiratory symptoms, fatigue level, neurological complaints, and medication status were documented. Her functional baseline was established, including a walking distance of approximately 160 metres. The daily care plan was explained to Simran and her family. Equipment was verified and the medication organizer was set up.
Family observations: Simran appeared relieved to be home but was noticeably cautious about moving around. She expressed concern about her ability to return to work. Mr. Gill was attentive to the instructions and asked detailed questions about what to watch for.
The daily routine began to take shape. Morning symptom reviews and medication administration became consistent. The first physiotherapy session was conducted, focusing on gentle range-of-motion exercises and a short supervised walk within the home. Fatigue was noted after the session, which was expected and consistent with the plan.
Nursing observations: Vital signs remained stable. Oxygen saturation stayed above 96% at rest. No new neurological symptoms were reported. Medication adherence was confirmed.
By the end of the first week, the daily care plan was functioning smoothly. Simran was consistently completing her morning stretching and breathing exercises. Physiotherapy sessions had progressed to include sit-to-stand training and short-distance walking within the home. The attendant was managing household tasks, allowing Simran to focus her energy on recovery activities.
Fatigue remained significant but was becoming more predictable. The family was learning to identify Simran’s energy patterns and adjust activities accordingly. No warning signs requiring urgent medical attention were observed.
Doctor review: No doctor home visit was required during the first week as no trigger criteria were met.
Physiotherapy progressed to include balance exercises and slightly longer walking distances. Sit-to-stand repetitions were increasing. Simran reported that the structured activity was making her feel more confident, even though her overall endurance was still limited. Respiratory symptoms remained stable with no new wheezing or increased breathlessness at rest.
The nurse noted that Simran’s fatigue was still present but the intensity was slightly less than the first week. The family symptom record was being maintained consistently.
Clinical observation: Foot numbness remained present but had not worsened. No new neurological findings.
At the four-week mark, a notable change was documented. Simran’s fatigue had become more manageable with the structured activity and rest pattern. She was able to complete short household activities without the excessive exhaustion that had characterized her first week at home. This did not mean the fatigue was gone, but its impact on daily life had reduced.
- Walking tolerance was improving steadily
- Balance exercises were showing measurable progress
- Lower-limb strengthening was progressing without adverse effects
- No falls had occurred
- Medication adherence remained consistent
Family observations: Mr. Gill reported that Simran seemed more like herself compared to the first week. Her mood had improved, and she was beginning to discuss returning to the boutique for at least some activities.
Walking tolerance had increased from the baseline of approximately 160 metres to approximately 220 metres. This represented a meaningful functional gain. Stair confidence had also improved, with Simran navigating stairs more smoothly and with less hesitation.
Respiratory symptoms remained stable. Oxygen saturation during and after walking remained within acceptable limits. The exertional breathlessness that had been present at the start of home care was still noticeable during faster walking but was less pronounced than before.
Neurological monitoring: Foot sensation remained stable. No new weakness or sensory changes were detected.
Simran resumed selected light administrative activities for her boutique. This included tasks that could be performed while seated, such as managing accounts, speaking with suppliers by phone, and planning inventory. She continued to avoid prolonged standing and heavy lifting as instructed.
This return to work, even in a limited capacity, had a positive psychological impact. Simran reported feeling more purposeful and engaged. The physiotherapy team adjusted the daily plan to accommodate her boutique activities while ensuring they did not replace her rehabilitation exercises.
Doctor review: A doctor home visit was conducted to assess overall progress and confirm that the pace of return to activity was appropriate. No concerns were identified that required specialist follow-up ahead of schedule.
At the 12-week assessment, the following outcomes were documented.
- Personal care remained fully independent
- Walking tolerance had increased to approximately 330 metres, more than double the baseline
- Lower-limb strength had improved based on standardized assessment
- Balance had improved, with greater confidence during ambulation
- Fatigue was better controlled with the pacing structure in place
- Respiratory symptoms remained stable with no acute exacerbation
- No fall-related hospitalization had occurred during the 12-week period
- Neurological symptoms remained stable and under ongoing monitoring
- Rheumatology and pulmonology follow-up visits were continuing as scheduled
Clinical Evidence
Vital Signs at First Home Assessment
| Parameter | Value | Clinical Interpretation |
|---|---|---|
| Blood Pressure | 126/78 mmHg | Within normal range |
| Heart Rate | 84 bpm | Normal sinus rhythm |
| Respiratory Rate | 18/min | Normal at rest |
| Temperature | 98.2 degrees F | Afebrile |
| SpO2 | 97% on room air | Adequate oxygenation |
Walking Tolerance Progression
| Time Point | Approximate Walking Distance | Change From Baseline |
|---|---|---|
| Baseline (Week 0) | 160 metres | Reference point |
| Week 6 | 220 metres | +60 metres (+37.5%) |
| Week 12 | 330 metres | +170 metres (+106%) |
Functional Status Summary
| Functional Domain | Baseline (Week 0) | Week 12 |
|---|---|---|
| Indoor Walking | Independent | Independent |
| Outdoor Walking | Supervision Required | Improved, Longer Distances |
| Stair Use | Slow, Independent | Improved Confidence |
| Basic ADL (Feeding, Dressing, Bathing) | Independent | Independent |
| Heavy Household Work | Assistance Required | Assistance Still Required |
| Prolonged Standing | Difficult | Improved but Limited |
| Boutique Work | Unable | Light Administrative Tasks |
| Fatigue Level | Significant | Better Controlled |
| Falls During Care Period | N/A | None |
Medical Authority
Supporting Clinical Documents
The following categories of clinical documentation informed this case study. Specific values and details from individual reports are referenced in the relevant sections above.
- Hospital discharge summary detailing admission diagnosis, treatment course, and discharge medications
- Blood investigation reports including eosinophil count and inflammatory markers
- Specialist evaluation notes from rheumatology, pulmonology, and neurology teams
- Home nursing assessment records and daily monitoring logs
- Physiotherapy progress notes and functional assessments
- Medication records and adherence documentation
- Family symptom monitoring records
Recovery Outcome
Mobility
Walking tolerance improved from approximately 160 metres at baseline to approximately 330 metres at 12 weeks. Stair confidence improved. Indoor walking remained independent throughout. Outdoor walking improved from requiring supervision to longer distances with greater confidence. No falls occurred during the 12-week care period.
Respiratory Status
Respiratory symptoms remained stable throughout the home care period. Exertional breathlessness was still present during faster walking but settled with rest. No acute asthma exacerbation occurred. No respiratory infection was identified. Oxygen saturation remained adequate at all recorded assessments.
Neurological Status
Foot numbness and tingling remained present but did not progress during the 12-week period. No new weakness developed. No foot drop was observed. Walking stability improved with the balance and strengthening exercises, despite the persistent sensory changes in the feet.
Fatigue
Fatigue improved from “significant” at baseline to “better controlled” at 12 weeks. The structured pacing approach helped Simran manage her energy more effectively. She was able to complete short household activities and light boutique tasks without the excessive exhaustion she experienced initially.
Functional Independence
Basic activities of daily living (feeding, dressing, bathing, grooming, toileting) remained independent throughout. Simran progressed from being unable to work at all to managing light administrative boutique tasks. Heavy household work and prolonged standing still required assistance at 12 weeks.
Remaining Challenges
At the end of the 12-week home care period, several challenges remained. The underlying EGPA was still present and required ongoing specialist treatment. Foot numbness was still present and required continued neurological monitoring. Fatigue, while better controlled, had not resolved. Heavy physical tasks still required assistance. Full return to boutique work with its demands of prolonged standing and stock handling had not yet been achieved.
Long-Term Care
The home care plan transitioned to a maintenance phase with continued specialist follow-up in rheumatology and pulmonology, ongoing neurological monitoring, continued physiotherapy at a reduced frequency, medication adherence support, and family vigilance for signs of disease flare or new complications. The family understood that EGPA is a long-term condition and that the improvement achieved through home care represented functional recovery, not a cure.
Key Clinical Learnings
- EGPA is a multisystem disease. Eosinophilic granulomatosis with polyangiitis is not simply a lung condition or a nerve condition. It is a systemic inflammatory vasculitis that can affect the respiratory tract, peripheral nerves, skin, musculoskeletal system, and other organs simultaneously. Home healthcare for EGPA must reflect this multisystem nature rather than focusing on a single organ.
- Asthma and eosinophilia are common but not sufficient for diagnosis. While asthma and eosinophilia are characteristic features of EGPA, the diagnosis requires evidence of systemic vasculitic involvement affecting other organs. In Simran’s case, the peripheral neuropathy was a key feature that elevated the clinical picture from “difficult asthma” to “systemic vasculitis.”
- Peripheral nerve involvement changes the rehabilitation approach. When a patient has foot numbness from neuropathy, balance training and fall prevention become central to the physiotherapy plan, not just strength and endurance. The sensory deficit means the patient has less feedback from the feet during walking, which affects balance and gait in ways that pure weakness does not.
- Normal rest vitals do not equal functional recovery. A patient with EGPA can have perfectly normal vital signs while sitting in a chair but be unable to walk 200 metres, stand for 15 minutes, or manage a work day. Functional assessment is essential and cannot be replaced by vital sign monitoring alone.
- Fatigue pacing is a clinical intervention, not just advice. In systemic vasculitis, fatigue is driven by inflammation, medications, deconditioning, and often sleep disruption. Teaching structured energy conservation with planned rest and graded activity increase is an evidence-based approach that produces measurable functional improvement.
- Medication adherence in chronic vasculitis affects outcomes. EGPA requires long-term immunomodulatory treatment. Non-adherence can lead to disease flare, organ damage, and potentially life-threatening complications. Home healthcare provides a structured mechanism for monitoring and reinforcing adherence that OPD visits alone cannot match.
- Infection prevention is a safety priority, not a lifestyle suggestion. Immunosuppressive treatment for vasculitis increases infection risk. For a patient who also has asthma and respiratory involvement, a respiratory infection is not just an inconvenience. It can trigger an asthma exacerbation, delay functional recovery, and in severe cases become life-threatening. Hand hygiene, exposure avoidance, and early reporting of fever symptoms are clinical safety measures.
- New neurological deficits require urgent reporting. Peripheral neuropathy in vasculitis can progress if the underlying inflammation is not controlled. New weakness, spreading numbness, or foot drop are not expected recovery symptoms. They are potential signs of disease progression that require same-day specialist communication.
- Functional improvement does not mean disease resolution. The walking distance improvement, fatigue reduction, and return to light work documented in this case represent physical reconditioning and symptom management. They do not mean the EGPA is gone. This distinction must be clearly communicated to patients and families to maintain appropriate treatment adherence and follow-up.
- Home healthcare complements but does not replace specialist care. The home care team monitored, supported, and rehabilitated. They did not diagnose, did not change medications, and did not make treatment decisions. The rheumatology, pulmonology, and neurology specialists retained full responsibility for the medical management of EGPA. Home healthcare operated within that framework, not outside it.
Frequently Asked Questions
EGPA is a rare inflammatory disease in which blood-vessel inflammation can affect multiple organs. It is commonly associated with asthma and increased eosinophils, a type of white blood cell. The disease can involve the lungs, sinuses, peripheral nerves, skin, heart, and other organ systems. It requires long-term medical management under specialist supervision.
Yes. Peripheral nerve involvement is one of the more common extra-pulmonary manifestations of EGPA. It can cause numbness, tingling, weakness, and difficulty walking. In some cases, it can lead to foot drop, where the patient cannot lift the front part of the foot. Any new or worsening neurological symptoms in a patient with EGPA should be reported to the treating specialist promptly.
Appropriately supervised physiotherapy can help improve strength, balance, endurance, and functional independence after an acute illness or period of reduced activity. In EGPA, physiotherapy must be carefully paced to account for respiratory limitations, fatigue, and peripheral neuropathy. Exercise intensity should be adjusted based on daily symptoms rather than following a rigid protocol.
Inflammation, respiratory disease, medications (particularly corticosteroids), and reduced physical conditioning can all contribute to fatigue in EGPA. Without structured management, patients often alternate between overexertion and crash, which delays recovery. Pacing and planned rest can help patients gradually increase activity in a sustainable way.
Caregivers should watch for increasing breathlessness (particularly if it occurs at rest or with less activity than before), new or worsening wheezing, persistent cough, chest tightness, fever, or a significant reduction in exercise tolerance. Any of these findings should be reported to the medical team. In a patient on immunosuppressive treatment, even a low-grade fever warrants prompt evaluation.
EGPA often requires long-term specialist-directed treatment to control inflammation and reduce the risk of organ damage or relapse. Skipping doses or stopping medications without medical guidance can lead to disease flare, which may cause new organ involvement or worsen existing damage. Medication changes should only be made by the treating specialist.
EGPA is a chronic condition. Treatment aims to control inflammation, achieve remission when possible, prevent organ damage, and maintain quality of life. Some patients achieve long-term remission, but the disease can relapse even after periods of stability. Ongoing specialist follow-up is essential regardless of how well the patient feels.
Severe breathing difficulty that does not improve with rest or prescribed reliever medication, rapidly worsening weakness in any limb, chest pain, confusion or altered consciousness, major neurological changes such as sudden foot drop or loss of sensation, significant oxygen desaturation (below 93% on room air), or any other severe acute symptoms require urgent medical evaluation. These situations warrant immediate hospital contact rather than waiting for a scheduled home visit.
Home healthcare in EGPA provides structured monitoring of respiratory and neurological status, supports medication adherence, delivers physiotherapy for functional reconditioning, implements fatigue management strategies, teaches infection prevention, and educates the family on warning signs. It fills the gap between hospital discharge and specialist OPD visits, where early signs of deterioration or complication might otherwise go unrecognized. It complements but does not replace specialist medical care.
Home healthcare can be safe for a patient with EGPA when certain conditions are met. The patient must be medically stable at the time of discharge. There must be a clear plan for what to monitor, what to report, and when to call for medical help. The home care team must understand the specific risks of EGPA, including respiratory deterioration and neurological progression. Specialist follow-up must be in place. And the family must be educated on emergency triggers. When these elements are in place, home nursing can be a safe and effective care setting for post-hospitalization recovery.
Contact Information
D1 Block, Malibu Town, Sector 47
Maholi, Haryana 122018
This case study is entirely fictional and created solely for educational purposes. It does not represent a real patient. Any resemblance to actual individuals is purely coincidental. The information provided is intended for education only and should not be used as a substitute for professional medical advice, diagnosis, or treatment.
Every patient is unique. Treatment decisions must always be made by qualified healthcare professionals based on individual clinical assessment. Emergency symptoms require immediate hospital care. Home healthcare complements, but does not replace, emergency medical services or specialist medical management.
If you or someone you know is experiencing symptoms similar to those described in this case study, please consult a qualified physician. Do not attempt to self-diagnose or self-treat based on this information.
Related Services
Home Nursing Services
Professional nursing care at home for post-hospitalization recovery, vital monitoring, and clinical support.
Patient Care Services
Comprehensive patient care including daily living assistance, companionship, and functional support at home.
Physiotherapy at Home
Expert physiotherapy for rehabilitation, strength recovery, balance training, and functional improvement.
Doctor Home Visit
Qualified doctors available for home visits when clinical assessment beyond nursing scope is required.
Patient Care Taker
Trained attendants for daily activity support, mobility assistance, and household help during recovery.
Medical Equipment Rental
Clinical-grade medical equipment on rent for home monitoring, rehabilitation, and patient comfort.
Patient Care in Chandigarh/Mohali
Dedicated home healthcare services for patients in Chandigarh, Mohali, and Panchkula region.
Home Healthcare Chandigarh Tricity
Complete home healthcare spectrum covering nursing, physiotherapy, and attendant services in the tricity area.